425: Strive CFO Alerts on Semler Merger Risks and Dilution

Strive, Inc.'s CFO posted a cautionary statement on X.com regarding the proposed business combination with Semler Scientific, Inc., highlighting inherent risks and uncertainties.

Summary

• A communication from Strive, Inc.'s CFO, Ben Pham, was posted on X.com on September 22, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement regarding forward-looking statements related to the merger, emphasizing that actual results could differ materially from anticipated outcomes.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and other relevant documents when they become available before making voting or investment decisions.
• Strive, Semler Scientific, and certain of their respective directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it is not an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement regarding a proposed merger, outlining both potential benefits and numerous risks. It is neutral in tone, focusing on legal disclosure rather than promotional language, hence a mid-range score.

Positives

• The proposed transaction aims to achieve strategic benefits and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected to be realized from the merger.

Negatives

• Integration of the two companies may prove more difficult, time-consuming, or costly than initially expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships could occur following the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.
• Dilution for existing shareholders of Strive is expected due to the issuance of additional shares of Class A common stock in connection with the proposed transaction.

Risks

• The occurrence of any event, change, or other circumstances could give rise to the right of one or both companies to terminate the merger agreement.
• The proposed transaction may not close when expected or at all if the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company could be adverse.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Changes in, or problems arising from, the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets could impact the combined company.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could affect the realization of anticipated benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities is a potential risk.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including strategic and financial benefits, expected impact on future financial performance, and timing of closing, are subject to inherent risks and uncertainties. Actual results may differ materially from anticipated outcomes.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., posted a communication on X.com on September 22, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

na

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of new Class A common stock.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Business and employee relationships at both companies could change as a result of the announcement or completion of the transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and other relevant documents filed with the SEC when they become available.

Key Dates

Recommendation

This filing is a procedural update and a cautionary statement regarding an already announced business combination. It highlights significant risks associated with the merger, including potential delays, integration difficulties, and dilution, but does not provide new financial performance data to warrant a change in investment thesis. Investors should hold and monitor the progress of the merger, paying close attention to the upcoming S-4 filing for more detailed information on terms and financial projections.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets